NP5 fundamentals
NEWRON PHARMACEUTICALS S.P.A. financial statements, including revenue, expenses, profit, and loss
The total revenue of NP5 for the last semiannual is 3.40 M EUR, and it's 7.34% lower compared to the previous semiannual. The net income of H1 24 is -9.54 M EUR.
0.00
Total revenue
Gross profit
Operating income
Pretax income
Net income
Currency: EUR
TTM